Glycogen storage disease type II: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
mNo edit summary |
||
| Line 45: | Line 45: | ||
==Treatment== | ==Treatment== | ||
[[Glycogen storage disease type II medical therapy|Medical Therapy]] | [[Glycogen storage disease type II surgery|Surgery]] | [[Glycogen storage disease type II primary prevention|Primary Prevention]] | [[Glycogen storage disease type II secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type II cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type II future or investigational therapies|Future or Investigational Therapies]] | [[Glycogen storage disease type II medical therapy|Medical Therapy]] | [[Glycogen storage disease type II surgery|Surgery]] | [[Glycogen storage disease type II primary prevention|Primary Prevention]] | [[Glycogen storage disease type II secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type II cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type II future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Glycogen storage disease type II case study one|Case #1]] | |||
[[fr:Maladie de Pompe]] | [[fr:Maladie de Pompe]] | ||
| Line 56: | Line 54: | ||
[[de:Morbus Pompe]] | [[de:Morbus Pompe]] | ||
[[es:Enfermedad de Pompe]] | [[es:Enfermedad de Pompe]] | ||
[[Category:Endocrinology]] | |||
[[Category:Hepatology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 20:13, 19 July 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
| Glycogen storage disease type II | |
| ICD-10 | E74.0 |
|---|---|
| ICD-9 | 271.0 |
| OMIM | 232300 |
| DiseasesDB | 5296 |
| MeSH | D006009 |
|
Glycogen storage disease type II Microchapters |
|
Differentiating Glycogen storage disease type II from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type II On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type II |
|
Directions to Hospitals Treating Glycogen storage disease type II |
|
Risk calculators and risk factors for Glycogen storage disease type II |
Synonyms and keywords: Glycogen storage disease type II; Pompe disease; acid maltase deficiency; glycogenosis type 2; alpha-1, 4-glucosidase deficiency
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glycogen storage disease type I from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Case #1 it:morbo di Pompe de:Morbus Pompe